Herein, we aimed to study the B cell responses upon TLRs agonists in AD-HIES patients, systematically evaluate the TLR-induced B cell response in patients with STAT3 mutations, including proliferation, apoptosis, surface marker expression, memory B cell subsets, cytokine, and immunoglobulin secretion. This evidence concerns the gene STAT3 and Alzheimer disease.